Since the SDF-1α/CRCX4 ligand-receptor interaction is heavily involved in stem cell migration in many forms of human disease and injury, manipulating this signaling pathway could also prove to be beneficial in maximizing the amount of NSCs that reach the infarct area of the brain following stroke. The gene discussed is CXCL12; the disease is stroke disorder.